A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : mTOR

Search Conditions:
Search Keyword : mTOR
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: mTOR
Appearance Frequency: 8717 time(s)
Long forms: 34

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
mammalian target of rapamycin
(8625 times)
Neoplasms
(1836 times)
PI3K (1079 times)
AMPK (504 times)
mTORC1 (307 times)
1995 Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.
mammalian TOR
(33 times)
Cell Biology
(9 times)
TOR (21 times)
S6K1 (2 times)
TORC1 (2 times)
1999 Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon.
molecular target of rapamycin
(17 times)
Neoplasms
(5 times)
PI3K (4 times)
CXCR4 (3 times)
EGFR (3 times)
2003 The molecular target of rapamycin (mTOR) as a therapeutic target against cancer.
mechanistic target of rapamycin (serine/threonine kinase)
(5 times)
Molecular Biology
(1 time)
PI3K (4 times)
AKT (2 times)
ATXN1 (1 time)
2014 New function of type I IFN: induction of autophagy.
mammalian target protein of rapamycin
(3 times)
Neoplasms
(2 times)
GA (1 time)
HIF-1alpha (1 time)
HSCs (1 time)
2013 Mechanistic/mammalian target protein of rapamycin signaling in hematopoietic stem cells and leukemia.
3-kinase-Akt-mechanistic target of rapamycin
(2 times)
Pediatrics
(1 time)
BCAP (1 time)
ccRCC (1 time)
IL (1 time)
2018 Renal Cell Carcinoma in von Hippel-Lindau Disease-From Tumor Genetics to Novel Therapeutic Strategies.
mammalian rapamycin target protein
(2 times)
Nephrology
(1 time)
CNI (1 time)
LC3II (1 time)
MMF (1 time)
2017 [Occurrence, diagnosis and treatment of de novo gastrointestinal malignancies after organ transplantation].
mammalian target of sirolimus
(2 times)
Drug Therapy
(1 time)
PBL (1 time)
SRL (1 time)
TDM (1 time)
2002 Update on pharmacokinetic/pharmacodynamic studies with FTY720 and sirolimus.
mitochondrial target of rapamycin
(2 times)
Molecular Biology
(1 time)
AM (1 time)
GSK-3beta (1 time)
IGF-1 (1 time)
2012 PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.
10  mTOR-complex
(2 times)
Neurology
(1 time)
GBM (2 times)
PI3K (2 times)
EGFR (1 time)
2016 PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma.
11  Akt-mammalian TOR
(1 time)
Biochemistry
(1 time)
OS (1 time)
2014 C6 ceramide sensitizes pemetrexed-induced apoptosis and cytotoxicity in osteosarcoma cells.
12  complex target of rapamycin
(1 time)
Rheumatology
(1 time)
SLE (1 time)
TSC (1 time)
2016 Coincidence of tuberous sclerosis and systemic lupus erythematosus-a case report.
13  downstream target of rapamycin
(1 time)
Physiological Phenomena
(1 time)
BFR (1 time)
ECC (1 time)
S6K1 (1 time)
2015 Blood flow restriction prevents muscle damage but not protein synthesis signaling following eccentric contractions.
14  integrin-mechanistic target of the Rapamycin
(1 time)
Cell Biology
(1 time)
BMSCs (1 time)
LIPUS (1 time)
2017 TGF-beta1-induced chondrogenesis of bone marrow mesenchymal stem cells is promoted by low-intensity pulsed ultrasound through the integrin-mTOR signaling pathway.
15  m Target of Rapamycin
(1 time)
Endocrinology
(1 time)
3-MA (1 time)
9-CPA (1 time)
9-mA (1 time)
2015 Monomethylated-adenines potentiate glucose-induced insulin production and secretion via inhibition of phosphodiesterase activity in rat pancreatic islets.
16  M: echanistic T: arget of R: apamycin
(1 time)
Neoplasms
(1 time)
--- 2016 Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy.
17  mammalian counterpart of TOR
(1 time)
Cell Biology
(1 time)
ERK5 (1 time)
TOR (1 time)
2008 Integration of protein kinases mTOR and extracellular signal-regulated kinase 5 in regulating nucleocytoplasmic localization of NFATc4.
18  mammalian homolog of target of rapamycin
(1 time)
Pharmacology
(1 time)
AMPK (1 time)
2005 AMPK, the metabolic syndrome and cancer.
19  mammalian homolog of the Saccharomyces cerevisiae target of rapamycin proteins
(1 time)
Biotechnology
(1 time)
eIF4E (1 time)
FKBP (1 time)
PKCdelta (1 time)
2000 Functional interaction between RAFT1/FRAP/mTOR and protein kinase cdelta in the regulation of cap-dependent initiation of translation.
20  mammalian target of rapamycin is an evolutionarily conserved serine-threonine kinase
(1 time)
Pharmacology
(1 time)
--- 2009 Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts.
21  mammalian target of rapamycin phosphorylation
(1 time)
Genetics, Medical
(1 time)
LPS (1 time)
siRNA (1 time)
2018 The transcription factor cMaf is targeted by mTOR, and regulates the inflammatory response via the TLR4 signaling pathway.
22  mammalian TOR homologue
(1 time)
Biochemistry
(1 time)
--- 1995 TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin.
23  mechanism by which a nutrient sensor
(1 time)
Science
(1 time)
YY1 (1 time)
2007 mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex.
24  mechanistic (formerly 'mammalian') target of rapamycin
(1 time)
Neurology
(1 time)
--- 2016 The mTOR signalling cascade: paving new roads to cure neurological disease.
25  mechanistic of rapamycin
(1 time)
Neurology
(1 time)
AMPK (1 time)
miRNAs (1 time)
NCDs (1 time)
2017 Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.
26  mechanistic target of rapamycin as it is known now
(1 time)
Neoplasms
(1 time)
ASH (1 time)
eIFs (1 time)
HCC (1 time)
2017 New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors.
27  mechanistic TOR
(1 time)
Cell Biology
(1 time)
TOR (1 time)
2013 Duration of rapamycin treatment has differential effects on metabolism in mice.
28  menopause, transplantologic age, CSD, previous glomerulonephritis, andmammalian target of rapamycin
(1 time)
Transplantation
(1 time)
BMD (1 time)
CSD (1 time)
imTOR (1 time)
2017 Understanding Bone Damage After Kidney Transplantation: ARetrospective Monocentric Cross Sectional Analysis.
29  metabolic regulator
(1 time)
Physiology
(1 time)
GOT (1 time)
qRT-PCR (1 time)
TG (1 time)
2017 Preventive effect of L-carnitine on the disorder of lipid metabolism and circadian clock of mice subjected to chronic jet-lag.
30  molecular target
(1 time)
Rheumatology
(1 time)
Tfh (1 time)
Th (1 time)
Treg (1 time)
2016 Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.
31  more effective than the rapamycin
(1 time)
Biomedical Engineering
(1 time)
PPARalpha (1 time)
TSC (1 time)
Vif (1 time)
2011 Systems analysis of small signaling modules relevant to eight human diseases.
32  MS and for drug and target protein
(1 time)
Pharmacology
(1 time)
--- 2018 Defining drug and target protein distributions after stent-based drug release: Durable versus deployable coatings.
33  mTOR Complex; RAS, Rat sarcoma; RAF, rapidly accelerated fibrosarcoma
(1 time)
Hematology
(1 time)
MB (1 time)
2016 Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor.
34  muscle protein synthesis
(1 time)
Nutritional Sciences
(1 time)
MAFbx (1 time)
MuRF-1 (1 time)
2014 Whey protein modifies gene expression related to protein metabolism affecting muscle weight in resistance-exercised rats.